192 related articles for article (PubMed ID: 17454888)
1. Analysis of neuroendocrine tumour metastases in the liver using contrast enhanced ultrasonography.
Mörk H; Ignee A; Schuessler G; Ott M; Dietrich CF
Scand J Gastroenterol; 2007 May; 42(5):652-62. PubMed ID: 17454888
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of diagnostic criteria for liver metastases of adenocarcinomas and neuroendocrine tumours at conventional ultrasound, unenhanced power Doppler sonography and echo-enhanced ultrasound.
Rickes S; Ocran KW; Gerstenhauer G; Neye H; Wermke W
Dig Dis; 2004; 22(1):81-6. PubMed ID: 15292699
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine tumors: characterization with contrast-enhanced ultrasonography.
Dörffel Y; Wermke W
Ultraschall Med; 2008 Oct; 29(5):506-14. PubMed ID: 19241507
[TBL] [Abstract][Full Text] [Related]
4. Contrast-enhanced sonography of nonfunctioning pancreatic neuroendocrine tumors.
Malagò R; D'Onofrio M; Zamboni GA; Faccioli N; Falconi M; Boninsegna L; Mucelli RP
AJR Am J Roentgenol; 2009 Feb; 192(2):424-30. PubMed ID: 19155405
[TBL] [Abstract][Full Text] [Related]
5. Role of contrast-enhanced ultrasound to define prognosis and predict response to biotherapy in pancreatic neuroendocrine tumors.
Del Prete M; Di Sarno A; Modica R; Lassandro F; Giorgio A; Bianco A; Muto M; Gasperi M; Del Prete F; Colao A; Montesarchio V; Faggiano A;
J Endocrinol Invest; 2017 Dec; 40(12):1373-1380. PubMed ID: 28667452
[TBL] [Abstract][Full Text] [Related]
6. [Baseline and contrast-enhanced ultrasound of the liver in tumor patients].
Oldenburg A; Albrecht T
Ultraschall Med; 2008 Oct; 29(5):488-98. PubMed ID: 19241505
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of benign and malignant portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma: color Doppler US, contrast-enhanced US, and fine-needle biopsy.
Tarantino L; Francica G; Sordelli I; Esposito F; Giorgio A; Sorrentino P; de Stefano G; Di Sarno A; Ferraioli G; Sperlongano P
Abdom Imaging; 2006; 31(5):537-44. PubMed ID: 16865315
[TBL] [Abstract][Full Text] [Related]
8. Contrast enhanced ultrasound for the diagnosis of liver hemangiomas in clinical practice.
Sirli R; Sporea I; Popescu A; Dănilă M; Martie A; Bota S; Jurchis A; Sendroiu M
Med Ultrason; 2011 Jun; 13(2):95-101. PubMed ID: 21655534
[TBL] [Abstract][Full Text] [Related]
9. Contrast-enhanced ultrasonography in evaluating hepatic metastases from neuroendocrine tumours.
Massironi S; Conte D; Sciola V; Pirola L; Paggi S; Fraquelli M; Ciafardini C; Spampatti MP; Peracchi M
Dig Liver Dis; 2010 Sep; 42(9):635-41. PubMed ID: 20172770
[TBL] [Abstract][Full Text] [Related]
10. Indeterminate, subcentimetric focal liver lesions in cancer patients: additional role of contrast-enhanced ultrasound.
Laghi F; Catalano O; Maresca M; Sandomenico F; Siani A
Ultraschall Med; 2010 Jun; 31(3):283-8. PubMed ID: 20517816
[TBL] [Abstract][Full Text] [Related]
11. Contrast enhanced ultrasound (CEUS) in the evaluation of liver metastases.
Dănilă M; Popescu A; Sirli R; Sporea I; Martie A; Sendroiu M
Med Ultrason; 2010 Sep; 12(3):233-7. PubMed ID: 21203602
[TBL] [Abstract][Full Text] [Related]
12. MR diagnosis of hepatic metastases from neuroendocrine tumors versus hemangiomas: relative merits of dynamic gadolinium chelate-enhanced gradient-recalled echo and unenhanced spin-echo images.
Soyer P; Gueye C; Somveille E; Laissy JP; Scherrer A
AJR Am J Roentgenol; 1995 Dec; 165(6):1407-13. PubMed ID: 7484575
[TBL] [Abstract][Full Text] [Related]
13. Contrast-enhanced ultrasound after devascularisation of neuroendocrine liver metastases: functional and morphological evaluation.
Guibal A; Lefort T; Chardon L; Benslama N; Mulé S; Pilleul F; Lombard-Bohas C; Bridal L; Chayvialle JA; Lucidarme O; Denys A; Walter T
Eur Radiol; 2013 Mar; 23(3):805-15. PubMed ID: 23001579
[TBL] [Abstract][Full Text] [Related]
14. Contrast-enhanced ultrasonography to detect liver metastases : a prospective trial to compare transcutaneous unenhanced and contrast-enhanced ultrasonography in patients undergoing laparotomy.
Konopke R; Kersting S; Bergert H; Bloomenthal A; Gastmeier J; Saeger HD; Bunk A
Int J Colorectal Dis; 2007 Feb; 22(2):201-7. PubMed ID: 16733650
[TBL] [Abstract][Full Text] [Related]
15. Contrast-enhanced ultrasound (CEUS) in hepatic lymphoma: retrospective evaluation in 38 cases.
Trenker C; Kunsch S; Michl P; Wissniowski TT; Goerg K; Goerg C
Ultraschall Med; 2014 Apr; 35(2):142-8. PubMed ID: 23888426
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Liver Metastases Using Contrast-Enhanced Ultrasound: Enhancement Patterns and Influencing Factors.
Kong WT; Ji ZB; Wang WP; Cai H; Huang BJ; Ding H
Gut Liver; 2016 Mar; 10(2):283-7. PubMed ID: 26586554
[TBL] [Abstract][Full Text] [Related]
17. Focal hypoechoic tumors of Fatty liver: characterization of conventional and contrast-enhanced ultrasonography.
Liu LP; Dong BW; Yu XL; Liang P; Zhang DK; An LC
J Ultrasound Med; 2009 Sep; 28(9):1133-42. PubMed ID: 19710210
[TBL] [Abstract][Full Text] [Related]
18. Value of contrast-enhanced ultrasonography in assessing the vascularity of liver metastases: comparison with contrast-enhanced computed tomography.
Zheng YL; Yin XY; Xie XY; Xu HX; Xu ZF; Liu GJ; Liang JY; Lu MD
J Ultrasound Med; 2010 Oct; 29(10):1403-10. PubMed ID: 20876893
[TBL] [Abstract][Full Text] [Related]
19. Contrast-enhanced ultrasound of histologically proven liver hemangiomas.
Dietrich CF; Mertens JC; Braden B; Schuessler G; Ott M; Ignee A
Hepatology; 2007 May; 45(5):1139-45. PubMed ID: 17464990
[TBL] [Abstract][Full Text] [Related]
20. Benefit of Contrast-Enhanced Ultrasound (CEUS) in the Follow-Up Care of Patients with Colon Cancer: A Prospective Multicenter Study.
Bernatik T; Schuler A; Kunze G; Mauch M; Dietrich CF; Dirks K; Pachmann C; Börner N; Fellermann K; Menzel J; Strobel D
Ultraschall Med; 2015 Dec; 36(6):590-3. PubMed ID: 26544634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
